Alphabet’s Stock Now Hinges on Cloud Growth and Backlog
Google Cloud’s explosive expansion is raising the stakes for Alphabet as investors measure AI demand against the cost of serving it.

Every Stocks story we have published, newest first.
81 stories in the last 24 hours
Updated 4:35 AM (Times shown in New York time (ET))
Page 22 of 23 · 548 stories
Google Cloud’s explosive expansion is raising the stakes for Alphabet as investors measure AI demand against the cost of serving it.

Investors marked down Olema after AstraZeneca’s SERENA-4 setback raised fresh questions about oral SERD drugs in breast cancer.

Oracle’s cloud infrastructure surge is strengthening its growth case, but enormous capital spending leaves investors focused on execution and cash flow.

Investors questioned the durability of AI infrastructure spending after industry leaders urged a slower pace for frontier-model development.

The pizza partnership tests whether Walmart can turn its fast-growing delivery infrastructure into a broader consumer platform beyond groceries.

The miner is exploring renminbi financing, but has stressed that no debt issuance has been approved.

Energy Transfer’s October move to TXSE gives the young venue an anchor issuer, but investors must weigh visibility against trading depth.

Pfizer’s 6% yield remains funded, yet weaker cash generation and heavy debt leave income investors with little room for error.

Micron, SanDisk and SK Hynix fell sharply as investors reassessed the infrastructure spending underpinning the AI boom.

AI’s next five years may reward companies controlling compute, distribution, power and enterprise workflows more than flashy model makers.

Tesla leans on support, Microsoft presses toward $500, while Amazon remains trapped between moving averages after Monday’s tech selloff.

RMD has trailed healthcare stocks over 12 months, but improving earnings, cash flow and buybacks complicate the bearish case.

Skyworks shares are surging on Qorvo deal progress, but the rally now carries execution, debt and valuation risks.

Weak direct sales, China’s slump and a tariff-driven margin boost leave Nike investors waiting for evidence of durable recovery.

Apple’s momentum is real, but Microsoft pairs faster cloud growth with a contracted enterprise pipeline that better supports its valuation.

Amazon’s operating cash flow is surging, yet a $220 billion investment plan complicates the bullish case for AMZN shares.

The new Ho Chi Minh City subsidiary creates a sales and distribution foothold, but Tesla has not disclosed launch timing or local production plans.

Lowe’s offers thinner sales momentum but stronger payout coverage as weak housing demand keeps pressure on both retailers.

AMD brings faster growth potential, but ASML’s monopoly on advanced lithography offers investors a sturdier way to play AI infrastructure.

AST SpaceMobile has cash, contracts and satellites, but its valuation already assumes a near-flawless commercial rollout.

GRMN has slipped from its August peak, but its three-month gain still outpaces technology stocks as earnings momentum strengthens.

The Danish drugmaker is pairing a consumer-facing rebrand with a culture reset as Eli Lilly widens its lead in obesity medicines.

Eaton’s power-infrastructure backlog contrasts with Rivian’s costly R2 ramp, making the choice hinge on certainty versus upside.

The five-company list spans retail, healthcare, entertainment and mortgage assets, with yields ranging from about 4% to 14%.
